Patent application number | Description | Published |
20100075947 | Methods of Using PI3K and MEK Modulators - The invention provides methods of treating cancer with a combination of compounds which inhibit kinases, more specifically MEK and PI3K. | 03-25-2010 |
20120252840 | Method of Treating Cancer - This invention is directed to the treatment of cancer, particularly ocular melanoma, with a dual inhibitor of MET and VEGF such as Compound 1. | 10-04-2012 |
20120282179 | Methods of Using C-Met Modulators - Methods of treating cancer by administering a compound of Formula I, | 11-08-2012 |
20120302545 | Method of Using PI3K and MEK Modulators - The invention provides methods of treating cancer with a combination of compounds which inhibit kinases, more specifically MEK and PI3K. | 11-29-2012 |
20130172371 | Methods of Treating Cancer Using Pyridopyrimidinone Inhibitors of PI3K and mTOR in Combination with Autophagy Inhibitors - The invention provides compounds of Formula I: | 07-04-2013 |
20140100215 | Methods of Using PI3K and MEK Modulators - The invention provides methods of treating cancer with a combination of compounds which inhibit kinases, more specifically MEK and PI3K. | 04-10-2014 |
20140121239 | METHOD OF TREATING LUNG ADENOCARCINOMA - This invention is directed to the treatment of cancer in a patient, particularly a patient with lung adenocarcinoma, and more particularly a patient with KIF5B-RET fusion-positive non-small cell lung cancer, with an inhibitor of MET, VEGF, and RET which is a compound of Formula I: | 05-01-2014 |
20140179736 | Method of Treating Cancer and Bone Cancer Pain - This invention is directed to the treatment of cancer, particularly lung cancer, breast cancer, melanoma, renal cell carcinoma, thyroid cancer that has metastasized to the bone. The invention is also directed to a method for treating bone cancer pain in an individual in need of such treatment comprising administering to the individual an effective amount of a compound of Formula I. | 06-26-2014 |
20140271665 | Combinations of Kinase Inhibitors for the Treatment of Cancer - The present invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3. | 09-18-2014 |
20140323522 | Method of Treating Cancer - This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and bone metastases, with a dual inhibitor of MET and VEGF. | 10-30-2014 |